267 related articles for article (PubMed ID: 25700239)
1. Giant cell tumors of the spine: has denosumab changed the treatment paradigm?
Goldschlager T; Dea N; Boyd M; Reynolds J; Patel S; Rhines LD; Mendel E; Pacheco M; Ramos E; Mattei TA; Fisher CG
J Neurosurg Spine; 2015 May; 22(5):526-33. PubMed ID: 25700239
[TBL] [Abstract][Full Text] [Related]
2. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
Al Farii H; McChesney G; Patel SS; Rhines LD; Lewis VO; Bird JE
Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904
[TBL] [Abstract][Full Text] [Related]
3. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
[TBL] [Abstract][Full Text] [Related]
4. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
[TBL] [Abstract][Full Text] [Related]
6. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
7. An assessment of the reliability of the Enneking and Weinstein-Boriani-Biagini classifications for staging of primary spinal tumors by the Spine Oncology Study Group.
Chan P; Boriani S; Fourney DR; Biagini R; Dekutoski MB; Fehlings MG; Ryken TC; Gokaslan ZL; Vrionis FD; Harrop JS; Schmidt MH; Vialle LR; Gerszten PC; Rhines LD; Ondra SL; Pratt SR; Fisher CG
Spine (Phila Pa 1976); 2009 Feb; 34(4):384-91. PubMed ID: 19214098
[TBL] [Abstract][Full Text] [Related]
8. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report.
Goto Y; Furuno Y; Kawabe T; Ohwada K; Tatsuzawa K; Sasajima H; Hashimoto N
J Neurosurg; 2017 Feb; 126(2):431-434. PubMed ID: 27177173
[TBL] [Abstract][Full Text] [Related]
9. Spondylectomy for Giant Cell Tumor After Denosumab Therapy.
de Carvalho Cavalcante RA; Silva Marques RA; dos Santos VG; Sabino E; Fraga AC; Zaccariotti VA; Arruda JB; Fernandes YB
Spine (Phila Pa 1976); 2016 Feb; 41(3):E178-82. PubMed ID: 26579960
[TBL] [Abstract][Full Text] [Related]
10. Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal.
Boriani S; Cecchinato R; Cuzzocrea F; Bandiera S; Gambarotti M; Gasbarrini A
Eur Spine J; 2020 Feb; 29(2):257-271. PubMed ID: 31098716
[TBL] [Abstract][Full Text] [Related]
11. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.
Thomas D; Henshaw R; Skubitz K; Chawla S; Staddon A; Blay JY; Roudier M; Smith J; Ye Z; Sohn W; Dansey R; Jun S
Lancet Oncol; 2010 Mar; 11(3):275-80. PubMed ID: 20149736
[TBL] [Abstract][Full Text] [Related]
12. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases.
Dubory A; Missenard G; Domont J; Court C
Spine (Phila Pa 1976); 2016 Jun; 41(11):E654-E660. PubMed ID: 27244112
[TBL] [Abstract][Full Text] [Related]
13. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.
Duan PG; Sheng YH; Deng CH; Tang BY; Yao HQ
BMC Musculoskelet Disord; 2020 Feb; 21(1):105. PubMed ID: 32061254
[TBL] [Abstract][Full Text] [Related]
14. An unusual giant cell tumor of the thyroid: case report and review of the literature.
Derbel O; Zrounba P; Chassagne-Clément C; Decouvelaere AV; Orlandini F; Duplomb S; Blay JY; de la Fouchardiere C
J Clin Endocrinol Metab; 2013 Jan; 98(1):1-6. PubMed ID: 23162095
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
Lau CP; Huang L; Wong KC; Kumta SM
Connect Tissue Res; 2013; 54(6):439-49. PubMed ID: 24060052
[TBL] [Abstract][Full Text] [Related]
16. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
Bardakhchyan S; Kager L; Danielyan S; Avagyan A; Karamyan N; Vardevanyan H; Mkhitaryan S; Papyan R; Zohrabyan D; Safaryan L; Sargsyan L; Harutyunyan L; Hakobyan L; Iskanyan S; Tamamyan G
Ital J Pediatr; 2017 Mar; 43(1):32. PubMed ID: 28356124
[TBL] [Abstract][Full Text] [Related]
17. Effect of denosumab on recurrent giant cell reparative granuloma of the lumbar spine.
Akeda K; Kasai Y; Sakakibara T; Matsumine A; Takegami N; Yamada J; Sudo A
Spine (Phila Pa 1976); 2015 May; 40(10):E601-8. PubMed ID: 25955096
[TBL] [Abstract][Full Text] [Related]
18. Giant cell tumor of the mobile spine: a review of 49 cases.
Boriani S; Bandiera S; Casadei R; Boriani L; Donthineni R; Gasbarrini A; Pignotti E; Biagini R; Schwab JH
Spine (Phila Pa 1976); 2012 Jan; 37(1):E37-45. PubMed ID: 22179322
[TBL] [Abstract][Full Text] [Related]
19. A system for surgical staging and management of spine tumors. A clinical outcome study of giant cell tumors of the spine.
Hart RA; Boriani S; Biagini R; Currier B; Weinstein JN
Spine (Phila Pa 1976); 1997 Aug; 22(15):1773-82; discussion 1783. PubMed ID: 9259790
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment for giant cell tumor of the thoracolumbar spine.
Yang SC; Chen LH; Fu TS; Lai PL; Niu CC; Chen WJ
Chang Gung Med J; 2006; 29(1):71-8. PubMed ID: 16642729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
